ASP Isotopes Inc. (ASPI) Income Statement
ASPI 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsASPI revenue and net income
Where ASPI's revenue goes
2025Each bar shows an amount and its share of revenue. ASPI kept −734.2% of revenue as net income.
ASPI profit margins
ASPI growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +475.5% | — | +1.1% | — |
| Gross profit | +112.9% | — | −20.6% | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ASPI quarterly EPS vs estimates
ASP Isotopes beat the analyst EPS estimate in 2 of the last 8 quarters. Next report: November 18, 2026.
ASPI income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|---|
| Revenue | $23.8M | $4.1M | $433,026 | $0 | $0 | $22.6M |
| Cost of revenue | $20.4M | $2.5M | $294,056 | $72,570 | $19,376 | $11.9M |
| Gross profit | $3.4M | $1.6M | $138,970 | −$72,570 | −$19,376 | $10.8M |
| Research & development | $12.4M | $3.1M | $764,581 | $1.3M | $41,610 | — |
| Sales, general & admin | $48.2M | $24.8M | $15.4M | $3.8M | — | $7.0M |
| Total operating expenses | $60.6M | $28.0M | $16.2M | $5.1M | $2.6M | $21.1M |
| Operating income | −$57.2M | −$26.4M | −$16.0M | −$5.1M | −$2.6M | −$10.3M |
| Interest income | $6.8M | $1.2M | $6,421 | $3,382 | — | — |
| Interest expense | $575,000 | $258,867 | $118,547 | $153,909 | — | — |
| Income before taxes | −$159.6M | −$32.3M | −$16.3M | −$4.9M | −$2.6M | −$10.4M |
| Income taxes | $282,000 | $111,449 | −$6,133 | −$153,909 | $4 | −$104,000 |
| Net income | −$175.1M | −$32.3M | −$16.3M | −$4.9M | −$2.6M | −$10.3M |
| EBITDA | −$157.1M | −$31.6M | −$16.1M | −$4.9M | −$2.6M | $3.8M |
| EPS (diluted) | −$1.71 | −$0.65 | −$0.49 | −$0.17 | −$0.08 | — |
| Gross margin | 14.3% | 38.6% | 32.1% | — | — | 47.6% |
| Operating margin | −239.8% | −636.0% | −3,704.6% | — | — | −45.3% |
| Net margin | −734.2% | −780.3% | −3,761.0% | — | — | −45.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1M | $4.2M | $16.7M | $4.9M | $1.2M | $1.1M | $1.2M | $1.1M | $1.0M | $840,354 | $433,026 | $0 |
| Cost of revenue | $3.6M | $2.5M | $14.6M | $4.5M | $626,247 | $774,765 | $588,141 | $793,714 | $601,275 | $561,484 | — | $802 |
| Gross profit | $1.5M | $1.7M | $2.1M | $423,178 | $572,098 | $326,840 | $605,737 | $293,981 | $421,024 | $278,870 | — | −$802 |
| Research & development | $6.8M | $5.3M | $6.8M | $3.1M | $879,925 | $1.5M | $1.4M | $1.0M | $473,302 | $215,134 | $65,168 | $239,199 |
| Sales, general & admin | $28.9M | $21.3M | $17.5M | $12.3M | $11.7M | $6.7M | $6.8M | $4.7M | $7.4M | $6.0M | $4.1M | $3.7M |
| Total operating expenses | $35.7M | $26.6M | $39.0M | $15.4M | $12.5M | $8.3M | $8.3M | $5.7M | $7.9M | $6.1M | $4.5M | $3.9M |
| Operating income | −$34.2M | −$24.9M | −$22.3M | −$15.0M | −$12.0M | −$8.0M | −$7.6M | −$5.4M | −$7.5M | −$5.8M | −$4.0M | −$3.9M |
| Interest income | $2.7M | $3.0M | $3.5M | $1.8M | $925,007 | $513,713 | $580,792 | $602,181 | $43,530 | $12,188 | $4,128 | $3,452 |
| Interest expense | $1.8M | $1.7M | $259,990 | $146,056 | $81,803 | $87,151 | $85,035 | $90,966 | $69,078 | $13,788 | — | $0 |
| Income before taxes | −$34.1M | −$26.7M | −$63.1M | −$12.8M | −$75.1M | −$8.5M | −$9.1M | −$7.4M | −$8.9M | −$7.0M | −$4.2M | −$4.2M |
| Income taxes | −$97,000 | −$31,000 | — | $73,629 | $95,238 | −$70,720 | $153,669 | −$8,370 | $13,769 | −$47,619 | — | −$802 |
| Net income | −$33.6M | −$6.9M | −$78.7M | −$12.9M | −$75.1M | −$8.4M | −$9.2M | −$7.3M | −$8.9M | −$6.9M | −$4.2M | −$4.2M |
| EBITDA | −$33.0M | −$21.8M | −$62.0M | −$12.4M | −$74.5M | −$8.3M | −$8.9M | −$7.1M | −$8.7M | −$6.9M | — | −$4.2M |
| EPS (diluted) | −$0.28 | −$0.05 | −$0.41 | −$0.15 | −$1.03 | −$0.12 | −$0.13 | −$0.12 | −$0.24 | −$0.16 | −$0.09 | −$0.14 |
| Gross margin | 28.9% | 39.9% | 12.5% | 8.7% | 47.7% | 29.7% | 50.7% | 27.0% | 41.2% | 33.2% | — | — |
| Operating margin | −667.5% | −595.4% | −133.9% | −306.1% | −998.8% | −721.9% | −640.6% | −499.6% | −729.5% | −691.9% | −929.1% | — |
| Net margin | −655.6% | −164.5% | −472.5% | −263.3% | −6,263.9% | −766.7% | −769.0% | −668.5% | −873.8% | −826.8% | −961.2% | — |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ASPI's financial statements (latest annual report filed April 10, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ASPI financial results
In fiscal year 2025 (ended December 31, 2025), ASP Isotopes reported revenue of $23.8 million, up 475.5% from the year before. It had a net loss of $175.1 million, a net profit margin of −734.2%. Diluted earnings per share came to −$1.71. Over five years revenue grew at an average rate of 1.1% a year.
See the ASPI stock overview for the latest quote and news, or the ASPI chart for price history and technical indicators.
ASPI income statement FAQ
What is ASP Isotopes's annual revenue?
ASP Isotopes reported total revenue of $23.8 million for fiscal year 2025, which ended on December 31, 2025. That was up 475.5% from $4.1 million the previous year.
Is ASP Isotopes profitable?
No. ASP Isotopes reported a net loss of $175.1 million in fiscal 2025, a net profit margin of −734.2%; its operating margin was −239.8%.
What is ASP Isotopes's gross margin?
ASP Isotopes's gross margin was 14.3% in fiscal 2025: for every $100 of revenue, ASP Isotopes kept $14 after the direct cost of its products and services.
How much does ASP Isotopes spend on research and development?
ASP Isotopes spent $12.4 million on research and development in fiscal 2025, 51.8% of revenue.
How fast is ASP Isotopes growing?
Revenue grew 1.1% a year on average over the last five fiscal years, from $22.6 million to $23.8 million.
What are ASP Isotopes's earnings per share?
ASP Isotopes earned $-1.71 per diluted share in fiscal 2025, compared with $-0.65 a year earlier.
When will ASP Isotopes report its next earnings?
ASP Isotopes is expected to report results for the quarter ending September 30, 2026 on November 18, 2026.
When does ASP Isotopes's fiscal year end?
ASP Isotopes's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on April 10, 2026.